BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 9623639)

  • 1. Allopregnanolone in women with premenstrual syndrome.
    Bicíková M; Dibbelt L; Hill M; Hampl R; Stárka L
    Horm Metab Res; 1998 Apr; 30(4):227-30. PubMed ID: 9623639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allopregnanolone concentrations and premenstrual syndrome.
    Monteleone P; Luisi S; Tonetti A; Bernardi F; Genazzani AD; Luisi M; Petraglia F; Genazzani AR
    Eur J Endocrinol; 2000 Mar; 142(3):269-73. PubMed ID: 10700721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects.
    Schmidt PJ; Purdy RH; Moore PH; Paul SM; Rubinow DR
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1256-60. PubMed ID: 7962316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone metabolite allopregnanolone in women with premenstrual syndrome.
    Rapkin AJ; Morgan M; Goldman L; Brann DW; Simone D; Mahesh VB
    Obstet Gynecol; 1997 Nov; 90(5):709-14. PubMed ID: 9351749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Correlation between neurotransmitters and neurosteroids and premenstrual syndrome patients of Gan-yang ascending syndrome and Gan-qi stagnation syndrome].
    Gao H; Xia T; Qiao MQ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Nov; 32(11):1503-7. PubMed ID: 23359974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GABAergic neuroactive steroid response to sertraline in premenstrual dysphoric disorder.
    Miller KN; Standeven L; Morrow AL; Payne JL; Epperson CN; Hantsoo L
    Psychoneuroendocrinology; 2024 Feb; 160():106684. PubMed ID: 38091917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Women with acute intermittent porphyria have a defect in 5α-steroid production during the menstrual cycle.
    Innala E; Bäckström T; Poromaa IS; Andersson C; Bixo M
    Acta Obstet Gynecol Scand; 2012 Dec; 91(12):1445-52. PubMed ID: 22924787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of a low dose of alcohol on allopregnanolone serum concentrations across the menstrual cycle in women with severe premenstrual syndrome and controls.
    Nyberg S; Andersson A; Zingmark E; Wahlström G; Bäckström T; Sundström-Poromaa I
    Psychoneuroendocrinology; 2005 Oct; 30(9):892-901. PubMed ID: 15979810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The allopregnanolone to progesterone ratio across the menstrual cycle and in menopause.
    Kimball A; Dichtel LE; Nyer MB; Mischoulon D; Fisher LB; Cusin C; Dording CM; Trinh NH; Yeung A; Haines MS; Sung JC; Pinna G; Rasmusson AM; Carpenter LL; Fava M; Klibanski A; Miller KK
    Psychoneuroendocrinology; 2020 Feb; 112():104512. PubMed ID: 31780185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adrenal response to adrenocorticotropic hormone stimulation in patients with premenstrual syndrome.
    Lombardi I; Luisi S; Quirici B; Monteleone P; Bernardi F; Liut M; Casarosa E; Palumbo M; Petraglia F; Genazzani AR
    Gynecol Endocrinol; 2004 Feb; 18(2):79-87. PubMed ID: 15195499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Moderate doses of ethanol fail to increase plasma levels of neurosteroid 3alpha-hydroxy-5alpha-pregnan-20-one-like immunoreactivity in healthy men and women.
    Holdstock L; Penland SN; Morrow AL; de Wit H
    Psychopharmacology (Berl); 2006 Jun; 186(3):442-50. PubMed ID: 16240164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroactive steroid-serotonergic interaction: responses to an intravenous L-tryptophan challenge in women with premenstrual syndrome.
    Rasgon N; Serra M; Biggio G; Pisu MG; Fairbanks L; Tanavoli S; Rapkin A
    Eur J Endocrinol; 2001 Jul; 145(1):25-33. PubMed ID: 11415849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of influence of menstrual cycle and premenstrual syndrome diagnosis on pregnanolone pharmacokinetics.
    Sundström I; Spigset O; Andersson A; Appelblad P; Bäckström T
    Eur J Clin Pharmacol; 1999 Apr; 55(2):125-30. PubMed ID: 10335907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allopregnanolone levels and reactivity to mental stress in premenstrual dysphoric disorder.
    Girdler SS; Straneva PA; Light KC; Pedersen CA; Morrow AL
    Biol Psychiatry; 2001 May; 49(9):788-97. PubMed ID: 11331087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5α-Reductase Inhibition Prevents the Luteal Phase Increase in Plasma Allopregnanolone Levels and Mitigates Symptoms in Women with Premenstrual Dysphoric Disorder.
    Martinez PE; Rubinow DR; Nieman LK; Koziol DE; Morrow AL; Schiller CE; Cintron D; Thompson KD; Khine KK; Schmidt PJ
    Neuropsychopharmacology; 2016 Mar; 41(4):1093-102. PubMed ID: 26272051
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study.
    Epperson CN; Haga K; Mason GF; Sellers E; Gueorguieva R; Zhang W; Weiss E; Rothman DL; Krystal JH
    Arch Gen Psychiatry; 2002 Sep; 59(9):851-8. PubMed ID: 12215085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex steroid induced negative mood may be explained by the paradoxical effect mediated by GABAA modulators.
    Andréen L; Nyberg S; Turkmen S; van Wingen G; Fernández G; Bäckström T
    Psychoneuroendocrinology; 2009 Sep; 34(8):1121-32. PubMed ID: 19272715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation between neurosteroids and neurotransmitters with liver yang rising and liver qi stagnation types of premenstrual syndrome.
    Gao H; Shang YZ; Xia T; Qiao MQ; Zhang HY; Ma YX
    Gynecol Endocrinol; 2014; 30(12):913-7. PubMed ID: 25211539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome.
    Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS
    Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTSD in women is associated with a block in conversion of progesterone to the GABAergic neurosteroids allopregnanolone and pregnanolone measured in plasma.
    Pineles SL; Nillni YI; Pinna G; Irvine J; Webb A; Arditte Hall KA; Hauger R; Miller MW; Resick PA; Orr SP; Rasmusson AM
    Psychoneuroendocrinology; 2018 Jul; 93():133-141. PubMed ID: 29727810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.